PhD Course: Innovation - from research to business in health sciences 2024

The PhD course trains young scientists in research commercialization through a series of inspirational and thematic talks combined with team exercises. Using scientific papers that have been the foundation of real spinouts, the teams will have to create an investor’s pitch to present and defend in front of a panel of investors their research commercialization plan using all the tools and knowledge they have gained during the course.

Enrollment deadline: October 18th, 2024    I     Read more and enroll: Graduate School of health and Medical Sciences (ku.dk)


Aim

The PhD course is aiming to train young scientists in research-based innovation through a series of inspirational and thematic talks combined with team exercises. Using scientific papers that have been the foundation of real spinouts, the teams will have to create an investor’s pitch to present and defend in front of a panel of investors their research commercialization plan using all the tools and knowledge they have gained during the course.

Content
Team creation, Ideation, Proof-of-Concept experiments, Market analysis, Business plan, Go-to-market Strategy, Intellectual property, Regulatory Affairs, Investments and funding, Company pitching.

Participants
The course is for PhD students at all levels with a natural interest and curiosity in innovation and research commercialization within the field of health and medical sciences, with a focus on therapeutics and medtech. The course does not require prior experience with innovation or research commercialization. Students with prior experience can, however, also benefit greatly from the course.

Speakers

(To be confirmed)

  • Trine Winterø, Vice Dean, Innovation and External Relations
  • Hans Wandall, Professor, Department of Cellular and Molecular Medicine
  • Ulrik Krogh Andersen, CEO at Mequ
  • Bo Hjorth Bentzen, Assistant Professor, Department of Biomedical Sciences
  • Kamilla Rolsted, Business Developer, Open Entrepreneurship
  • Ali Salanti, Professor, Centre for Medical Parasitology
  • Janine Terra Erler, Professor, BRIC
  • Tony Cheng-Fu Chang, Business Developer at BII
  • Niels Lysholm Engelhard, Technology Transfer Office
  • Ann Christine Korsgaard, Regulatory expert and Director at Ozack
  • Henriette Schultz Kirkegaard, Co-funder 3DIntegrated
  • Jørgen Søberg Petersen, Partner at Novo Holdings
  • Sanne Brun Jensen, Business Developer at BII
  • Jacob Moresco, Investment Director at Sunstone Life Science Venture
  • Anna Vestergård Jacobsen, Innovation Consultant, The Pipeline & KU Lighthouse
  • Peter Løvschall, Innovation Consultant, The Pipeline & KU Lighthouse
  • Mette Trauelsen, CEO at SOLID Therapeutics
  • Peter J. Holst, Associate Professor, Department of Biomedical Sciences

Register for the course